FR2073431A1 - - Google Patents

Info

Publication number
FR2073431A1
FR2073431A1 FR7042668A FR7042668A FR2073431A1 FR 2073431 A1 FR2073431 A1 FR 2073431A1 FR 7042668 A FR7042668 A FR 7042668A FR 7042668 A FR7042668 A FR 7042668A FR 2073431 A1 FR2073431 A1 FR 2073431A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7042668A
Other versions
FR2073431B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aspro Nicholas Ltd
Original Assignee
Aspro Nicholas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aspro Nicholas Ltd filed Critical Aspro Nicholas Ltd
Publication of FR2073431A1 publication Critical patent/FR2073431A1/fr
Application granted granted Critical
Publication of FR2073431B1 publication Critical patent/FR2073431B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7042668A 1969-11-28 1970-11-27 Expired FR2073431B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB58203/69A GB1287475A (en) 1969-11-28 1969-11-28 Aspirin formulations

Publications (2)

Publication Number Publication Date
FR2073431A1 true FR2073431A1 (fr) 1971-10-01
FR2073431B1 FR2073431B1 (fr) 1974-03-22

Family

ID=10481023

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7042668A Expired FR2073431B1 (fr) 1969-11-28 1970-11-27

Country Status (19)

Country Link
US (1) US3882228A (fr)
JP (1) JPS516727B1 (fr)
AT (1) AT302533B (fr)
BE (1) BE759520A (fr)
CA (1) CA948108A (fr)
DE (1) DE2058434C3 (fr)
DK (1) DK130453B (fr)
ES (1) ES385974A1 (fr)
FR (1) FR2073431B1 (fr)
GB (1) GB1287475A (fr)
IE (1) IE34756B1 (fr)
IL (1) IL35714A (fr)
IN (1) IN129401B (fr)
MX (1) MX3244E (fr)
NL (1) NL165928C (fr)
OA (1) OA03600A (fr)
SE (1) SE383099B (fr)
ZA (1) ZA707915B (fr)
ZM (1) ZM13470A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535937A1 (fr) * 1991-10-01 1993-04-07 Takeda Chemical Industries, Ltd. Préparation à base de microparticules à libération prolongée et production de celle-ci
FR2708853A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636152C2 (de) * 1976-08-11 1980-11-06 Arcana Chem.-Pharm. Fabrik Gmbh, Spittal, Drau (Oesterreich) Verfahren zur Herstellung von Dragees
JPS5364921A (en) * 1976-11-24 1978-06-09 Yasumi Aoki Method of sliding snowfall on metal roof
JPS5373831A (en) * 1976-12-11 1978-06-30 Keiichi Abe Snow sliding roof
US4251518A (en) * 1979-07-03 1981-02-17 Ralston Purina Company Method of preparing readily disintegrable pharmaceutical compositions
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS58110745A (ja) * 1981-12-22 1983-07-01 株式会社西部技研 屋根の積雪防止装置
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4459280A (en) * 1982-07-23 1984-07-10 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
JPS6152012U (fr) * 1984-09-12 1986-04-08
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
US5238686A (en) * 1986-03-27 1993-08-24 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
DE4027927A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Brausekomponente und verfahren zu ihrer herstellung
US5085852A (en) * 1991-04-19 1992-02-04 The Procter & Gamble Company Antimicrobial oral compositions
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
DE19606151C2 (de) 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
EP0913178A1 (fr) * 1997-11-03 1999-05-06 Boehringer Mannheim Gmbh Procédé pour la préparation de produits amorphes et sec comprenant des matériaux biologiques actifs utilisant un séchage convectif et produits obtenus
EP0913177A1 (fr) 1997-11-03 1999-05-06 Roche Diagnostics GmbH Procédé pour produire des produits amorphe, sec comprenant de la matière biologique active par séchage convectif, spécialement söchage par pulvérisation
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US6555141B1 (en) 1998-02-27 2003-04-29 Nutramax Laboratories, Inc. L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
WO2003074029A1 (fr) * 2002-03-07 2003-09-12 Vectura Limited Formulations a base de particules multiples a fusion rapide pour administration orale
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2502986C (fr) 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1727522A2 (fr) * 2004-02-04 2006-12-06 Foamix Ltd. Mousse cosmetique et pharmaceutique comprenant des matieres solides
BRPI0612428A2 (pt) * 2005-05-09 2010-11-09 Foamix Ltd composição farmacêutica higroscópica, veìculo farmacêutico espumoso e composição farmacêutica espumosa
AU2006271230A1 (en) 2005-07-22 2007-01-25 Warner Chilcott Company, Llc Compositions for reducing the incidence of drug induced arrhythmia
EP1757274B1 (fr) * 2005-08-08 2012-07-25 Stada Arzneimittel Ag Composition effervescente contre les symptomes du rhume
CN101489414B (zh) * 2006-07-12 2013-05-22 普拉克生化公司 部分中和的酸涂层的食品级颗粒
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009090495A2 (fr) 2007-12-07 2009-07-23 Foamix Ltd. Vecteurs moussants siliconés à base d'huile et de liquide, et formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
MX2011008671A (es) 2009-04-01 2011-09-06 Colgate Palmolive Co Composiciones dentifricas y metodos para el tratamiento y prevencion del deterioro de las superficies dentales.
CA2760186C (fr) 2009-04-28 2019-10-29 Foamix Ltd. Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776366C (fr) 2009-10-02 2017-07-18 Foamix Ltd. Compositions moussantes sans eau et sans surfactant, mousses et gels friables, ainsi que leurs utilisations
US9492395B2 (en) * 2010-05-11 2016-11-15 Sensient Colors Llc Film coating composition and methods of making and using the same
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10022328B2 (en) * 2015-02-20 2018-07-17 Cytec Industries Inc. Dialkyl sulfosuccinate compositions, method of making, and method of use
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
BR112022023307A2 (pt) 2020-05-18 2022-12-20 Orexo Ab Composição farmacêutica para entrega de fármacos
EP4236921A1 (fr) 2021-11-25 2023-09-06 Orexo AB Composition pharmaceutique comprenant de l'adrénaline

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299504A (fr) * 1959-04-15 1962-07-27 Philips Nv Procédé de préparation de produits secs pour poudrage, stables à l'air, contenant en particulier des substances douées d'activité biologique
GB1128192A (en) * 1964-12-04 1968-09-25 Organon Labor Ltd Process for rendering powders free flowing and the thus-obtained powders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
US3293132A (en) * 1963-03-25 1966-12-20 Merck & Co Inc Spray dried vitamin compositions and method of preparation
US3384546A (en) * 1965-05-28 1968-05-21 Miles Lab Directly compressed low-density crystalline sorbitol pharmaceutical tablets

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299504A (fr) * 1959-04-15 1962-07-27 Philips Nv Procédé de préparation de produits secs pour poudrage, stables à l'air, contenant en particulier des substances douées d'activité biologique
GB1128192A (en) * 1964-12-04 1968-09-25 Organon Labor Ltd Process for rendering powders free flowing and the thus-obtained powders

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535937A1 (fr) * 1991-10-01 1993-04-07 Takeda Chemical Industries, Ltd. Préparation à base de microparticules à libération prolongée et production de celle-ci
US5622657A (en) * 1991-10-01 1997-04-22 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
US5651990A (en) * 1991-10-01 1997-07-29 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
FR2708853A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.
FR2708852A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.

Also Published As

Publication number Publication date
DK130453C (fr) 1975-07-21
NL165928C (nl) 1981-06-15
ZA707915B (en) 1971-08-25
OA03600A (fr) 1971-03-30
DK130453B (da) 1975-02-24
FR2073431B1 (fr) 1974-03-22
DE2058434C3 (de) 1980-12-18
CA948108A (en) 1974-05-28
DE2058434B2 (de) 1980-04-24
IL35714A0 (en) 1971-01-28
DE2058434A1 (de) 1971-06-03
GB1287475A (en) 1972-08-31
JPS516727B1 (fr) 1976-03-02
NL165928B (nl) 1981-01-15
MX3244E (es) 1980-08-06
BE759520A (fr) 1971-04-30
SE383099B (sv) 1976-03-01
IL35714A (en) 1974-03-14
NL7017417A (fr) 1971-06-02
US3882228A (en) 1975-05-06
IE34756B1 (en) 1975-08-06
ZM13470A1 (en) 1971-11-22
IE34756L (en) 1971-05-28
ES385974A1 (es) 1973-05-01
AT302533B (de) 1972-10-25
IN129401B (fr) 1975-08-16

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU465413B2 (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442554B2 (fr)
AU442322B2 (fr)
AU442463B2 (fr)
AU442535B2 (fr)
AU442538B2 (fr)
AU470661B1 (fr)
AU442357B2 (fr)
AT308690B (fr)
AU442380B2 (fr)
AU442285B2 (fr)
AU4949169A (fr)
AU5228269A (fr)
AU4540468A (fr)
AU5109569A (fr)
AU5077469A (fr)
AR203167Q (fr)
BG17761A3 (fr)
AU4953367A (fr)